Utah Medical Products, Inc. Stock price

Equities

UTMD

US9174881089

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:26:05 2024-03-28 pm EDT 5-day change 1st Jan Change
70.98 USD +1.15% Intraday chart for Utah Medical Products, Inc. +3.28% -15.96%
Sales 2022 52.28M Sales 2023 50.22M Capitalization 306M
Net income 2022 16M Net income 2023 16M EV / Sales 2022 5.55 x
Net cash position 2022 74.66M Net cash position 2023 92.53M EV / Sales 2023 4.24 x
P/E ratio 2022
22.2 x
P/E ratio 2023
18.4 x
Employees 180
Yield 2022
1.16%
Yield 2023
1.41%
Free-Float 94.59%
More Fundamentals * Assessed data
Dynamic Chart
Utah Medical Products Keeps Quarterly Dividend at $0.30 Per Share, Payable on April 3 to Shareholders on March 15 MT
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Utah Medical Products, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
North American Morning Briefing : Microsoft Kicks -2- DJ
Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992. CI
Utah Medical Products Lifts Quarterly Dividend by 1.7% to $0.30 a Share, Payable Jan. 3 to Shareholders of Record as of Dec. 15 MT
Utah Medical Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
North American Morning Briefing : Yields Fall -2- DJ
Utah Medical Products Maintains Quarterly Dividend at $0.295/Share, Payable Oct. 3 to Shareholders of Record Sept. 15 MT
Utah Medical Products, Inc. Approves Quarterly Cash Dividend, Payable on October 3, 2023 CI
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 Revenue $12.9M MT
Earnings Flash (UTMD) UTAH MEDICAL PRODUCTS Posts Q2 EPS $1.15 MT
Utah Medical Products, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
North American Morning Briefing : Alphabet, -2- DJ
More news
1 day+1.15%
1 week+3.28%
Current month+0.85%
1 month+1.26%
3 months-17.62%
6 months-19.71%
Current year-15.96%
More quotes
1 week
68.00
Extreme 68
70.94
1 month
68.00
Extreme 68
72.02
Current year
68.00
Extreme 68
85.76
1 year
68.00
Extreme 68
100.59
3 years
68.00
Extreme 68
133.87
5 years
68.00
Extreme 68
133.87
10 years
44.52
Extreme 44.52
133.87
More quotes
Managers TitleAgeSince
Chief Executive Officer 77 92-11-30
Director of Finance/CFO 54 05-12-31
Director/Board Member 64 89-12-31
Members of the board TitleAgeSince
Chief Executive Officer 77 92-11-30
Director/Board Member 86 95-12-31
Director/Board Member 64 89-12-31
More insiders
Date Price Change Volume
24-03-28 70.78 +0.85% 13 237
24-03-27 70.18 +2.99% 31,829
24-03-26 68.14 -1.74% 51,197
24-03-25 69.35 +1.14% 49,201
24-03-22 68.57 +0.06% 80,679

Delayed Quote Nasdaq, March 28, 2024 at 03:11 pm EDT

More quotes
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. The Company's products include BT-CATH, CVX-RIPE, CVX-RIPE, MUC-X, AROM-CO, DISPOSA-HOOD, DELTRAN PLUS, EPITOME and OptiMicro Electrosurgical Devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, and LUMIN. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock
  2. Equities
  3. Stock Utah Medical Products, Inc. - Nasdaq